Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Graft-versus-host disease (GVHD) is the most important complication of allogeneic hematopoietic stem cell transplantation (alloHSCT). We performed a prospective randomized, multicenter, phase 3 trial to study whether posttransplant cyclophosphamide (PT-Cy) combined with a short course of cyclosporin...

Descripción completa

Detalles Bibliográficos
Autores principales: Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus, de Groot, Marco R., van Gelder, Michel, Kuball, Jürgen, van der Holt, Bronno, Meijer, Ellen, Cornelissen,, Jan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198908/
https://www.ncbi.nlm.nih.gov/pubmed/35143644
http://dx.doi.org/10.1182/bloodadvances.2021005847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198908/
https://www.ncbi.nlm.nih.gov/pubmed/35143644
http://dx.doi.org/10.1182/bloodadvances.2021005847

Ejemplares similares